← Eichor
Study identifier: NCT06272669 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents

Condition: Transcranial Direct Current Stimulation · Autistic Spectrum Disorder · Electroencephalography  ·  Sponsor: The Hong Kong Polytechnic University

PhaseNA
Planned participants90
Who can joinAll sexes, 12 Years to 21 Years
Healthy volunteersNo

About this study

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by disturbances in communication, poor social skills, and aberrant behavior. To date, ASD has no known cure, and the disorder remains a highly disabling condition. Recently, transcranial direct-current stimulation (tDCS), a non-invasive brain stimulation technique, has shown great promise as a potentially effective and cost-effective tool for reducing the core symptoms in patients with autism, such as anxiety, aggression, impulsivity, and inattention. Although the preliminary findings in patients with ASD are encouraging, it remains to be determined whether this experimental data can translate into benefits in real life. Further studies are needed to determine the factors that can lengthen the therapeutic effects or cognitive benefits of tDCS, and to determine possible risk factors associated with relapse in patients with ASD. Booster sessions of tDCS is an important component of treatment planning and prognosis and may promote better outcomes to control for resurgence of symptoms. This study has three aims. First, the investigators aim to evaluate the therapeutic effects of tDCS on improving cognitive function in patients with ASD. Second, the investigators aim to better understand the neural mechanisms underlying the neuro-enhancing effects of tDCS in patients with ASD. Third, the investigators aim to assess the effectiveness of booster treatment cycles of tDCS for enhancing cognitive and social f…

This description comes directly from the study's public registry record.

Talk to the study team

Yvonne Han, PhD  ·  +852 2766 7578  ·  yvonne.han@polyu.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

The Hong Kong Polytechnic UniversityHung Hom, Kowloon, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06272669